President Trump signed an executive order directing federal health agencies to review the US childhood and adolescent vaccine schedule.

Delayed treatment escalation, initial antibiotic therapy use, and timing differences in therapy initiation were noted in pediatric patients with HS.

In patients with AK, lesion clearance with PDT is comparable to that of cryotherapy, although anatomical location may affect clearance rates.

Researchers report on the use of a digital patient navigation platform to foster meaningful engagement between physicians and patients with melanoma.

Dupilumab showed superiority to tralokinumab among patients with AD, although the absolute differences were small among responders.

From pre- to postmenopause, there is a decline in crude overall American Heart Association's Life's Essential 8 (LE8) score.

Early-onset AD can negatively impact educational and professional trajectories, imparting lifelong consequences.

Congress’ decision not to extend enhanced marketplace tax credits has boosted the appeal of alternatives to comprehensive insurance.

In patients with previously untreated metastatic uveal melanoma and HLA-A*02:01 positivity, tebentafusp is associated with long-term OS benefit.

Inconsistent prior authorization rules across major commercial insurers increase administrative burden and delay patient care.

Certain common screenings, procedures, and drugs have risks that may outweigh the benefits for older patients.

Patients who initiated therapy with a GLP-1 RA may be at an increased risk for hair loss, with women experiencing the greatest risk.